Micro-Cap
Candel Therapeutics Reports Encouraging Survival Data for CAN-2409 in Pancreatic Cancer
Updated Interim Results Show Prolonged Survival and Immune Activation in Borderline Resectable PDAC Patients Candel Therapeutics (CADL), a clinical-stage biopharmaceutical...
ARCA Biopharma and Oruka Therapeutics Announce Merger to Pave the Way for Advanced Biologic Treatments
Combined Entity Aims to Revolutionize Chronic Skin Disease Treatment with Cutting-Edge Antibodies ARCA biopharma (ABIO) and Oruka Therapeutics have finalized...
KULR Technology’s $1M Contract Revolutionizes Electric Aviation Safety with H55
Cutting-edge Thermal Runaway Shield Technology to Enhance Compliance and Performance KULR Technology Group (KULR), a trailblazer in sustainable energy management,...
CXApp Inc. Partners with Google Cloud to Revolutionize Workplace Experiences
Innovative AI-Native Platform to Shape Future of Work CXApp Inc. (CXAI) has unveiled a groundbreaking partnership with Google Cloud to...
Xilio Therapeutics Secures Funding for Clinical Advancement of Cancer Therapies
Strategic Reprioritization and Partnership with Gilead Sciences Propel Xilio's Innovative Oncology Pipeline Xilio Therapeutics (XLO), a leading biotechnology firm specializing...
LIXTE Biotechnology’s LB-100 Unveils Novel Cancer Treatment Strategy
Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States LIXTE Biotechnology Holdings, Inc. has made a groundbreaking...
KULR Technology Fortifies Defense Sector with Lockheed Martin Partnership
Innovative PCM Heat Sinks to Revolutionize Thermal Regulation in Precision Missiles KULR Technology Group (KULR) a prominent player in sustainable...
Yield10 Hits Regulatory Milestone for Omega-3 Camelina
USDA's Approval Signals Advancement in Land-Based Production of Essential Fatty Acids Yield10 Bioscience (YTEN) has achieved a significant regulatory milestone,...
IGC Pharma’s IGC-AD1 Shows Promising Results in Alzheimer’s Agitation Trial
Interim Analysis Reveals Statistically Significant Reduction in Agitation Levels IGC Pharma (IGC) has unveiled encouraging findings from its ongoing Phase...
XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction
Expanding Portfolio Strengthens XTL's Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has...
